PD+H: How do SMEs and MNCs approach transactions?

This event was held on Friday 10 November 2023

This webinar aims to give you the perspective from the other side of the table so you can be better prepared when entering into negotiations with Pharma.

Specific topics include:

  • Current state of play in Pharma transactions – an overview
  • Understanding Pharma motivators
  • Types and stage of deals
  • The role of the deal champion
  • Finding the win-win outcome
  • The integration process – beyond the deal

Who should attend

  • PhD students
  • Postdoctoral researchers
  • Early and mid-career researchers
  • Industry-engaged academics
  • Industry-engaged professional staff

What you'll experience

PD+ is a free weekly webinar series that takes place every Friday from 12-1PM. It is the perfect way to lunch and level up your industry engagement and commercialisation skills.

Meet your presenter: Rob Crombie

Rob Crombie is currently the VIC/TAS State Lead for i4 Connect delivering the Federal Governments Accelerating Commercialisation programme through his role as Managing Director of Concept2Clinic Consulting, a specialist professional services company looking to turn smart innovation into commercial ventures. Rob has held previous roles as the CEO of VC backed QUE Oncology Incorporated, as well as the founding CEO of ASX-listed Prescient Therapeutics, in-licensing early stage drug candidates from Universities including Yale and Emory University and built value by advancing these assets through company sponsored clinical trials.

Register Here

Event is free but registration is essential.

The PD+ webinar series is brought to you by the University of Newcastle's Knowledge Exchange and Enterprise (KEE) and Campus Plus.  Find out about upcoming PD+ webinars and catch up on recordings of previous PD+ webinars at the Research Advantage Knowledge Hub.


What is KEE?

The University of Newcastle's Knowledge Exchange and Enterprise (KEE) is responsible for facilitating impact within our regions through intellectual property commercialisation, business development, and entrepreneurship. KEE works with researchers and industry to identify and facilitate high-value licenses and research collaborations, in addition to supporting pre-startups, startups, and scale-up companies.